BridgeMD
New treatment option for Diabetic Group (n=30)
Official title Evaluation of Aqueous Humor DEL-1 and IL-17 Levels in Diabetic Cataract Patients
ClinicalTrials.gov ID: NCT06995131
What this study is testing
- What it's testing
- By comparing DEL-1 and IL-17 levels in the aqueous humor of diabetic cataract patients with the aqueous humor of non-diabetic patients, we aim to understand the biochemical effects of diabetes-related inflammatory processes in the eye.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 80. Healthy volunteers may be eligible.
You may be able to join if
- Cataract diagnosed and surgery planned
- Patients without any other ocular pathology other than cataract.
- Type 2 DM for at least 5 years in the diabetic group
You likely can't join if
- Patients with previous intraocular surgery
- Those with inflammatory eye diseases (e.g. uveitis)
- Those with autoimmune diseases or systemic inflammatory diseases
- Those receiving local or systemic steroid therapy
- Those with severe systemic disease (e.g. advanced renal failure, malignancy)
The study team makes the final eligibility decision.
Where it's taking place
- Uşak, Uşak, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 80 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Uşak, Uşak, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.